Factors Influencing Morbidity Trends in BRIC Countries


December 1, 2011
SKU: DECR6727327
License type:
Countries covered: China, India, Russia, Brazil

The WHO projects that, over the next ten years, the largest increase in deaths from cardiovascular disease, cancer, respiratory disease, and diabetes will occur in countries with developing or transitional economies. In addition to population dynamics and demographic changes (including urbanization), smoking and obesity are two key factors that will drive morbidity trends in Brazil, Russia, India, and China (the "BRIC" countries).

Questions Answered

  • Emerging markets, particularly the BRIC countries, are being primed for robust economic growth and represent an enticing pharmaceutical opportunity. What are the overall key factors influencing morbidity trends in the BRIC countries? What are some health-related consequences associated with the rapid expansion of these countries?
  • Both similarities and differences in morbidity trends exist among the BRIC countries. What are some salient trends in obesity and smoking that will drive the morbidity of chronic noncommunicable diseases in these countries?
  • Escalating rates of obesity and smoking can be viewed as a function of a transitional economy; however, statistics indicate that these trends will not likely level off within the foreseeable future. What issues have been identified on a global scale that will lead to significant improvements in risk factors for chronic disease?
Please note, the PDF e-mail from publisher version of this report is for a global site license.



More Oncology/Hematology reports by Decision Resources

TreatmentTrends®: Advanced/Metastatic Breast Cancer (US) 2012 by Decision Resources
This report series examines the current trends in the management of Advanced / Metastatic Breast Cancer from the perspective of medical oncologists. TreatmentTrends® are syndicated ...
Breast Cancer in Mexico by Decision Resources
Over the next decade, the diagnosed  incidence of breast cancer (CaB) in Mexico will increase at almost three times the average annual growth ...
Oncology Patient Flow Model: Ovarian Cancer by Decision Resources
Query multiple epidemiological parameters over a 20 year forecast period in a data rich, graphical and interactive environment with Pharmacor Patient Flow Models.Please ...
Ovarian Cancer by Decision Resources
Few novel therapies have entered the ovarian cancer (CaO) market in recent history, and oncologists are particularly keen to welcome new market entrants ...
See all reports like this >>

More Brazil Oncology/Hematology reports

Payer and Clinician Perspectives on the Role of Premium-Priced Angiogenesis Inhibitors in Brazil and Mexico by Decision Resources
This Emerging Markets Physician and Payer Forum explores dynamics that affect sales of angiogenesis inhibitors in Brazil and Mexico, and dynamics that will ...
Gastric Cancer - Brazil, Russia, India and China (BRIC) Drug Forecasts and Treatment Analysis to 2020 by GlobalData
Gastric Cancer - Brazil, Russia, India and China (BRIC) Drug Forecasts and Treatment Analysis to 2020SummaryGlobalData, the industry analysis specialist, has released its new report, ...
Prostate Cancer - BRIC Drug Forecasts and Treatment Analysis to 2020 by GlobalData
Prostate Cancer - BRIC Drug Forecasts and Treatment Analysis to 2020 Summary GlobalData's pharmaceutical report, “Prostate Cancer - Brazil, Russia, India and China ...
Colorectal Cancer - Brazil, China, India and Russia (BRIC) Drug Drug Forecasts and Treatment Analysis to 2020 by GlobalData
Colorectal Cancer - Brazil, China, India and Russia (BRIC) Drug Drug Forecasts and Treatment Analysis to 2020SummaryGlobalData, the industry analysis specialist, has released its new ...
See all reports like this >>

More Brazil reports

D&B Country RiskLine Report: Brazil by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
Spirits - BRIC (Brazil, Russia, India, China) Industry Guide by MarketLine
Spirits - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and analysis covering the BRIC (Brazil, Russia, India, China) ...
Chemicals: Advanced Emerging Markets (Brazil, Hungary, Mexico, Poland, South Africa, Taiwan) Industry Guide by MarketLine
Chemicals: Advanced Emerging Markets (Brazil, Hungary, Mexico, Poland, South Africa, Taiwan) Industry Guide is an essential resource for top-level data and analysis covering the Chemicals ...
Soft Drinks: Advanced Emerging Markets (Brazil, Hungary, Mexico, Poland, South Africa, Taiwan) Industry Guide by MarketLine
Datamonitor's Soft Drinks: Advanced Emerging Markets (Brazil, Hungary, Mexico, Poland, South Africa, Taiwan) Industry Guide is an essential resource for top-level data and analysis covering ...
See all reports like this >>

 
Research assistance
We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!